Drug Shortage Report for AVAPRO
| Report ID | 153358 |
| Drug Identification Number | 02237924 |
| Brand name | AVAPRO |
| Common or Proper name | Avapro 150mg |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-03-08 |
| Actual start date | |
| Estimated end date | 2022-06-10 |
| Actual end date | 2022-06-01 |
| Shortage status | Resolved |
| Updated date | 2022-06-09 |
| Company comments | Manufacturing Issue The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2022-06-09 | French | Compare |
| v8 | 2022-06-09 | English | Compare |
| v7 | 2022-03-09 | English | Compare |
| v6 | 2022-03-04 | French | Compare |
| v5 | 2022-03-04 | English | Compare |
| v4 | 2022-02-10 | French | Compare |
| v3 | 2022-02-10 | English | Compare |
| v2 | 2022-01-21 | French | Compare |
| v1 | 2022-01-21 | English | Compare |
Showing 1 to 9 of 9